Sign In
Buy IFRX
$1.70
-0.0200 (-1.16%)
At Close: Jul 31, 2026
20 Healthcare Stocks Moving In Wednesday's Pre-Market Session
11:45am, Wednesday, 01'st Apr 2020
Gainers
• InflaRx, Inc. (NASDAQ:IFRX) shares increased by 93.19% to $7.38 during Wednesday's pre-market session.
• Chembio Diagnostics, Inc. (NASDAQ:CEMI) shares...
The Daily Biotech Pulse: InflaRx Begins Human Testing For COVID-induced Pneumonia, Chembio, Becton Dickinson Launch Coronavirus Tests
11:38am, Wednesday, 01'st Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 31) * Athersys Inc (NASDAQ: ATHX) * Forty Seven Inc (NA
31 Stocks Moving in Wednesday's Pre-Market Session
11:18am, Wednesday, 01'st Apr 2020
Gainers
InflaRx N.V. (NASDAQ: IFRX) shares rose 133% to $8.90 in pre-market trading after the company announced it dosed the first patient in a clinical study with IFX-1 in...
Inflarx NV (NASDAQ:IFRX) Given Average Rating of "Hold" by Analysts
05:36am, Wednesday, 01'st Apr 2020
Inflarx NV (NASDAQ:IFRX) has been given an average recommendation of “Hold” by the ten analysts that are presently covering the firm, Marketbeat reports. Two analysts have rated the stock with a s
6 Stocks Moving In Tuesday's After-Hours Session
08:39pm, Tuesday, 31'st Mar 2020
Gainers
AVEO Pharmaceuticals (NASDAQ: AVEO) shares are trading higher after the company announced the submission of a new drug application to the FDA for Tivozanib in...
InflaRx N.V. (IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, today announced the enrollment of the first patient into a
InflaRx has dosed the first patient in an adaptive randomized controlled clinical study with IFX-1 in patients with severe COVID-19 pneumonia in the...
17 Healthcare Stocks Moving In Tuesday's Pre-Market Session
11:58am, Tuesday, 31'st Mar 2020
Gainers
• Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) stock surged 104.67% to $8.33 during Tuesday's pre-market session.
• Owens & Minor, Inc. (NYSE:OMI) stock...
Inflarx (NASDAQ:IFRX) Trading Down 13.6%
08:22am, Friday, 13'th Mar 2020
Inflarx NV (NASDAQ:IFRX)’s stock price fell 13.6% during trading on Wednesday . The company traded as low as $3.18 and last traded at $3.23, 755,400 shares were traded during mid-day trading. An inc
Inflarx NV (NASDAQ:IFRX) Given Average Rating of "Hold" by Analysts
07:32am, Saturday, 07'th Mar 2020
Inflarx NV (NASDAQ:IFRX) has earned a consensus rating of “Hold” from the ten brokerages that are presently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the
4 Smaller, Cash-Rich Biotech Stocks That Could Be Havens
03:49pm, Friday, 06'th Mar 2020
“A volatile, risk-off environment could make these relative outperformers,” writes Jeffries’ Michael Yee.
Inflarx (NASDAQ:IFRX) Trading Down 8%
07:46am, Friday, 06'th Mar 2020
Inflarx NV (NASDAQ:IFRX)’s stock price fell 8% on Thursday . The company traded as low as $4.06 and last traded at $4.16, 671,000 shares were traded during mid-day trading. An increase of 13% from t
Healthcare dominates premarket losers amidst coronavirus situation
02:23pm, Tuesday, 03'rd Mar 2020
Spherix (NASDAQ:SPEX) -25%.Dynatronics (NASDAQ:DYNT) -22%.China Pharma Holdings (NYSEMKT:CPHI) -19%.Co-Diagnostics (NASDAQ:CODX) -17%.Tilray (NASDAQ:TLRY) -14% on Q4 earnings.Cleveland BioLabs (NAS
Best & Worst ADRs - Tuesday, March 3
01:16pm, Tuesday, 03'rd Mar 2020
The top-ranked sectors are healthcare, utilities, and technology. Services are neutral.
Inflarx (NASDAQ:IFRX) Upgraded to Strong-Buy at ValuEngine
09:04am, Tuesday, 03'rd Mar 2020
Inflarx (NASDAQ:IFRX) was upgraded by research analysts at ValuEngine from a “buy” rating to a “strong-buy” rating in a research report issued on Tuesday, ValuEngine reports. Separately, Zacks
